Long-Antagonist protocol; a new protocol where a bolus luteal dose of long-acting GnRH-antagonist Degarelix can efficiently downregulate LH during ovarian stimulation for IVF addressing flexibility in an antagonist protocol

Long-Antagonist protocol; a new protocol where a bolus luteal dose of long-acting GnRH-antagonist Degarelix can efficiently downregulate LH during ovarian stimulation for IVF addressing flexibility in an antagonist protocol

The purpose of that study was to examine whether a bolus luteal dose of a new longacting GnRH-antagonist can be compared with the classical short with follicular multiple doses antagonist protocol

Ελέγχθηκε από Συμβουλευτική Επιτροπή Μ.Ι.Υ.Α.
Αναθεωρήθηκε: Απρίλιος 2021